Advertisement

Related Videos

Peter Clark, MA, MD, FRCP: A Payer Perspective

Opportunities to Optimize Cancer Policies Panel Discussion

The Interventional Pharmacoeconomic Toolbox Panel Discussion

David A. Hyman, MD, JD, on Inclusive Shared Savings

Mark Sculpher, PhD: How Do We Assess the Value of Cancer Drug Optimization?

Advertisement

Advertisement




Feb
06
Today In Oncology
Chemotherapy-Free Regimen Improves Outcomes in Newly Diagnosed Patients With Ph-Positive ALL
Early Results Show Pirtobrutinib Matches Ibrutinib in BTK Inhibitor-Naive CLL
Colorectal Cancer Liver Metastases: Transplant or Resect?
Metastasis-Directed Therapy for Oligometastatic Prostate Cancer
New European Project Cluster EARLYSCAN Launched to Advance Early Detection of Heritable Cancers
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo